Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid sequential therapy in pediatric drug-resistant and severe tuberculosis
ChiCTR2100042287Phase 4Recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of linezolid in Tuberculosis (TB) (2 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoint: Symptoms improved and/or etiology turned negative. Started Jan 2021; status: recruiting.
02
Drugs
linezolid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2100042287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042287.